FTC Wants More Info On Curium's $8B Deal For Lantheus
The Federal Trade Commission has requested additional information about Curium's planned $8 billion acquisition of fellow radiopharmaceutical company Lantheus Holdings Inc., extending a waiting period that prevents the transaction from closing....To view the full article, register now.
Already a subscriber? Click here to view full article